A phase 1 study evaluating ABT-414 in combination with temozolomide (TMZ) for subjects with recurrent or unresectable glioblastoma (GBM) Conference Paper uri icon

authors

  • Gan, Hui Kong
  • Fichtel, Lisa
  • Lassman, Andrew B
  • Merrell, Ryan
  • Van Den Bent, Martin J
  • Kumthekar, Priya
  • Scott, Andrew Mark
  • Pedersen, Michelle
  • Gomez, Erica
  • Fischer, JuDee
  • Ames, William
  • Xiang, Hao
  • Dudley, Matthew W
  • Munasinghe, Wijith
  • Roberls-Rapp, Lisa
  • Ansell, Peter
  • Holen, Kyle D
  • Reardon, David A

publication date

  • May 20, 2014